According to Merck's latest financial reports the company's current earnings are $64.16 Billion USD. , an increase over its 2023 earnings that were of $3.03 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | $21.20 B | 598.75% |
2023 | $3.03 B | -82.56% |
2022 | $17.40 B | 18.52% |
2021 | $14.68 B | 80.8% |
2020 | $8.12 B | -34.26% |
2019 | $12.35 B | 30.45% |
2018 | $9.47 B | 30.2% |
2017 | $7.27 B | 35.93% |
2016 | $5.35 B | -11.87% |
2015 | $6.07 B | -66.29% |
2014 | $18.01 B | 183.88% |
2013 | $6.34 B | -32.87% |
2012 | $9.45 B | 17.32% |
2011 | $8.05 B | 240.11% |
2010 | $2.36 B | -84.96% |
2009 | $15.74 B | 66.09% |
2008 | $9.48 B | 68.8% |
2007 | $5.61 B | 52.38% |
2006 | $3.68 B | -37.16% |
2005 | $5.86 B | -11.41% |
2004 | $6.62 B | -20.89% |
2003 | $8.37 B | -11.74% |
2002 | $9.48 B | -2.51% |
2001 | $9.72 B | 7.03% |
2000 | $9.08 B | 19.69% |
1999 | $7.59 B | 19.1% |
1998 | $6.37 B | 12.52% |
1997 | $5.66 B | 13.68% |
1996 | $4.98 B |